Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
More info
Helsinn Grants Exclusive Licensing Rights to Berlin-Chemie Menarini, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region
27 Jan 2020
Helsinn Grants Exclusive Licensing Rights to Berlin-Chemie Menarini, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region
Lugano, Switzerland and Berlin, Germany, January 27, 2020 : Helsinn Group (“Helsinn”), a Swiss pharmaceutical group focused on building quality cancer care products, has granted exclusive licensing rights to commercialize A...
Read more
Menarini’s Sustenium product line launched on Tmall
20 Dec 2019
Menarini’s Sustenium product line launched on Tmall
Menarini Consumer Healthcare  has entered a partnership with  Alibaba , one of the world’s leading technology companies, by opening a  flagship store on Tmall
Read more
61st ASH Congress 2019: Menarini Ricerche presents the latest updates about the First In Human clinical trial of SEL24/MEN1703
09 Dec 2019
61st ASH Congress 2019: Menarini Ricerche presents the latest updates about the First In Human clinical trial of SEL24/MEN1703
Menarini Ricerche is progressing with the clinical development of SEL24/MEN1703, and will be presenting the design of the ongoing First In Human clinical trial DIAMOND-01 (NCT03008187) at the 61 st  ASH Congress
Read more
The delicate artistry of Fra Angelico is now a part of the Menarini Art Series
23 Sep 2019
The delicate artistry of Fra Angelico is now a part of the Menarini Art Series
Fra Giovanni da Fiesole, known to the world as Fra Angelico, "Angelic friar”, truly believed that each brush stroke came from...
Read more
Press Release
29 Mar 2019
Press Release
Page available only in italian language 
Read more
The Menarini Group announces meropenem/vaborbactam European marketing authorization
20 Dec 2018
The Menarini Group announces meropenem/vaborbactam European marketing authorization
Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections. The first combination of a carbapenem and a beta-lactamase inhibitor...
Read more
Page 1 of 2First   Previous   [1]  2  Next   Last